2011
DOI: 10.1016/j.fertnstert.2010.12.041
|View full text |Cite
|
Sign up to set email alerts
|

Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
20
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(22 citation statements)
references
References 14 publications
(15 reference statements)
1
20
0
Order By: Relevance
“…The majority of published studies regarding ovarian reserve have not demonstrated significant differences between patients with malignancy and their age-matched controls [18][19][20][21], although some authors have reported significantly lower AMH levels in patients with lymphoma [22] and lower AFC in women with cancer than in healthy controls [23]. Analyzing the ovarian reserve status was not the main goal of the current study but the observed data do not seem to reveal diminished ovarian reserve ( Table 1).…”
Section: Discussionmentioning
confidence: 64%
“…The majority of published studies regarding ovarian reserve have not demonstrated significant differences between patients with malignancy and their age-matched controls [18][19][20][21], although some authors have reported significantly lower AMH levels in patients with lymphoma [22] and lower AFC in women with cancer than in healthy controls [23]. Analyzing the ovarian reserve status was not the main goal of the current study but the observed data do not seem to reveal diminished ovarian reserve ( Table 1).…”
Section: Discussionmentioning
confidence: 64%
“…In general, breast cancer patients tended to need higher doses and longer administration of fsh 3 , to show reduced maximal levels of estradiol on betahuman chorionic gonadotropin administration day, and to have a reduced number of oocytes 6,9 . Those observations might be explained by the relatively older age of patients diagnosed with breast cancer (Quintero et al found a higher degree of poor response among breast cancer patients).…”
Section: Discussionmentioning
confidence: 97%
“…Moria et al 6 reported lower baseline levels of fsh for patients with hematologic malignancy, but similar levels of fsh in control subjects and in patients with breast cancer and other types of cancer. The younger age of patients with hematologic malignancies (mostly Hodgkin lymphoma) in all probability explains the statistical difference.…”
Section: Levin Md* and B Almog Md*mentioning
confidence: 89%
See 2 more Smart Citations